Since most of the KRAS-mutated lesions analyzed by immunohistochemistry in this study carried the more frequent codon 12 mutation, it could be argued that there might be different signalling patterns in carcinoma cells carrying activating mutations in codon 13 that might lead to nuclear translocation of Abi1. This evidence concerns the gene KRAS and carcinoma.